Back to today’s briefing

Story perspectives

Eli Lilly, a16z Launch $500M Biotech Venture Fund

1/11/2025

22 5

Summary

Story summary

Eli Lilly and Andreessen Horowitz (a16z) have joined forces to unveil a groundbreaking $500 million Biotech Ecosystem Venture Fund. This powerful collaboration merges Lilly's cutting-edge research and development with a16z's venture capital prowess, fueling the growth of innovative biotech startups and paving the way for transformative treatments and therapies.

1 of 1

Story summary

Eli Lilly and Andreessen Horowitz (a16z) have joined forces to unveil a groundbreaking $500 million Biotech Ecosystem Venture Fund. This powerful collaboration merges Lilly's cutting-edge research and development with a16z's venture capital prowess, fueling the growth of innovative biotech startups and paving the way for transformative treatments and therapies.